The Food and Drug Administration said Wednesday it approved a new drug from Biogen Idec to control multiple sclerosis in adults with hard-to-treat forms of the disease.
123993
FDA approves new drug for multiple sclerosis
165731
New epilepsy drug may significantly reduce seizures
130150
FDA approves first cord blood product
25962
BioElectronics Corp. to announce results from acetaminophen
155843
La Jolla Institute for Allergy and Immunology receives $7.1 million grant from the National Institutes of health (NIH)
83632
Galapagos initiates second phase I clinical trial for GLPG0259
57802
Pepscan achieves a breakthrough with CLIPS immunogen technology:
91207
Us Food and Drug Administration extends action date for dapagliflozin by three months
71088
DuoCort's new form of treatment improves cardiovascular & metabolic measures:
170957
What's New With the FDA?
103390
SurModics signs licensing and development agreement with Roche and Genentech
112598
FDA clears first test to diagnose Q fever in military personnel serving overseas
17962
US Food and drug Administration issues complete response letter regarding
157784
BioElectronics announces revolutionary device for treatment of
90632
Scientists discover potential drug delivery system
153612
Antisoma starts phase IIb trial of AS1411
67830
Scientists use stem cells to reverse symptoms of multiple sclerosis